FRAMINGHAM, Mass.--(BUSINESS WIRE)--GTC Biotherapeutics, Inc. (“GTC” or “the Company”, NASDAQ: GTCB) received notice from the Listing Qualifications Staff (“Staff”) of The NASDAQ Stock Market indicating that GTC has regained compliance with the minimum market value of listed securities requirement for continued listing on The NASDAQ Capital Market, as set forth in Marketplace Rule 5550 (b)(2), by exceeding $35 million of market capitalization for 10 consecutive trading days.
